
Zydus’ oncology business is supported by early entry into complex biologics and targeted therapies, along with structured patient support programmes that have improved access across treatment lines
The personalized medicine market is experiencing strong growth driven by advances in genomics, biomarker-based diagnostics, and targeted therapies. The increasing prevalence of chronic diseases and cancer is accelerating demand for tailored treatment approach…